Healthcare industry

Press release - 19/01/2011

Baden-Württemberg funds innovative ideas in biotechnology and medical technology

The Baden-Württemberg government is planning to exploit the enormous research potential in the fields of biotechnology and medical technology even better than in the past. As part of this objective, the Baden-Württemberg Ministry of Science, Research and the Arts launched an idea competition for which a jury has now selected 42 winning projects. The winners are now being given the opportunity to test their ideas in feasibility studies. The…

Press release - 26/11/2012

Textile pressure ulcer prevention

Immobile patients are in constant danger of developing pressure ulcers on the skin. Empa, Schoeller Medical and the Swiss Paraplegic Centre have worked together to develop a special sheet that is gentle on the skin and helps to make patients more comfortable.

Article - 20/02/2012

Microporation: an innovative laser replaces jabs

People who are afraid of needles now have something to celebrate: hypodermic needles, which have long been the key instrument for administering drugs used to treat allergies and diseases as well as for vaccinations, now have a serious competitor. The minimally invasive P.L.E.A.S.E. ® platform developed by Pantec Biosolutions AG combines a laser device and stick-on patches to deliver drugs transdermally and painlessly into the bloodstream. The…

Article - 01/02/2010

Innovative and award-winning: vascular implants “Made in Hechingen”

On the 26th November 2009, the Hechingen-based medical technology company JOTEC GMBH was awarded the Baden-Württemberg Innovation Prize. JOTEC specialises in solutions for the therapy of vascular diseases. The company’s “E-vita open” is an innovative hybrid stentgraft system for use in cardiac surgery. The stentgraft is ideal for treating the thoracic aorta as it significantly simplifies therapeutic procedures at the same time as putting less…

Press release - 28/11/2010

Cardiac catheter surgery for children and young adults without X-ray radiation

Heart specialists and electrophysiologists from Tübingen University Hospital have succeeded for the first time in Germany in treating cardiac arrhythmia without the need for X-ray radiation. This was done through the selection of a new method to control the contact force between the catheter and the blood vessel and cardiac walls. The intervention was successfully carried out on a 16-year-old girl and is regarded as a very attractive alternative…

The Ulm-based Institute for Laser Technologies in Medicine and Metrology (ILM) has received a 335,000 euro injection in 2009 through the German government’s Future Investment Programme (Economic Stimulus Packet II), according to the Baden-Württemberg Minister of Economic Affairs Ernst Pfister. The funds, 75 per cent of which are provided by the German government and 25 per cent by the state of Baden-Württemberg, will be used for the modernisation…

Press release - 04/02/2010

QIAGEN acquires ESE GmbH

QIAGEN N.V. has announced its acquisition of ESE GmbH a privately owned developer and manufacturer of UV and fluorescence optical measurement devices. ESE GmbH is based in Stockach Germany. The cash transaction is valued at up to US19 million.

While there are specific regulations in Germany for the reimbursement of medicines, funding for molecular diagnostics products is complex and virtually non-existent. There is hardly any medical insurance cover for medical devices, which therefore tend to be sold on the open market. The question therefore arises as to how a reasonable price can be determined for innovative diagnostic methods and tools. In the second part of the interview conducted…

Article - 31/12/2012

Diagnosis of myocardial infarction: a drop of blood is all that is required

Can myocardial infarction be diagnosed with a single drop of blood? The answer is yes: a new application of the ESEQuant Lateral Flow System developed by QIAGEN now makes this possible. The system, which is able to identify a broad range of bacterial and viral pathogens, including HIV, influenza virus and Chlamydia, was originally developed at the company’s site in Stockach. It has recently been adapted for use in the diagnosis of myocardial…

Press release - 05/04/2011

HARTMANN continues its success

Profitability improved despite difficult market conditions: In fiscal year 2010, HARTMANN continued its profitable growth despite unfavorable market conditions, building on its strong sales performance in the previous year. The company was confronted with increasing budget restrictions in the health systems and substantially higher raw material and logistics costs.

Press release - 11/05/2010

Bright future for medtech companies

According to Ernst Young medical technology is one of the most innovative industries in the German economy with total sales of around EUR 19 billion and a workforce of almost 100000. The export rate is 65 and despite the financial crisis the sector is continuing to grow. Medical technology made in Germany enjoys an excellent reputation throughout the world. That is the conclusion of Heinrich Christen partner and medtech expert at Ernst Young…

Article - 12/04/2010

A new strategy for improving bone implants

Biomechanics is an interdisciplinary field of research and is also of great interest to aerospace engineers. Aerospace engineers at the University of Stuttgart develop equations and models in order to gain a better understanding of the interaction between bones and implants. In addition, they believe that their results will contribute to developing new implants and implant structures.

Article - 21/03/2011

Fluoron – a company that is well underway

Fluoron is a company that takes close contact with customers very seriously. This is why Christian Lingenfelder and his team frequently pack their suitcases to travel from place to place visiting Russian or Chinese operating theatres. Thousands of kilometres from the company’s production site in Ulm, the Fluoron team exchanges information with the retina surgeons for whom the company develops and produces highly pure biomaterials for use in…

The World Health Organization is seeking innovative technologies, in particular medical devices that offer solutions to global health concerns in low- and middle-income countries. The deadline for submission of proposals is January the 31st 2010.

Press release - 27/11/2010

Help for lung emphysema patients

Around one million people in Germany suffer from lung emphysema as a result of chronic obstructive pulmonary disease. The Department of Internal Medicine II at the University Hospital in Ulm Pneumology Division offers a minimally invasive method that is able to improve lung function by way of tiny endobronchial valves. Ulm University Hospital is thus the first centre in southern Germany to offer treatment involving endobronchial valves.

Press release - 08/04/2010

Next step towards international cooperation

Representatives from companies and research institutes based in the STERN BioRegion met metalworking and surface treatment specialists in France. The collaboration between BioRegio STERN Management GmbH and Ple Technologique de Haute-Champagne PTHC opens up the way for making new contacts sharing innovative ideas and exploring cooperation options.

Press release - 13/03/2011

Vascular stent that dissolves on its own

The first ever implant in Germany of a bioresorbable, drug-coated stent in a cardiac patient has been carried out by physicians from the University of Heidelberg. In contrast to traditional metal stents, which remain permanently in the patients’ body, the innovative implant dissolves around two years after the procedure is carried out.

Press release - 07/11/2011

Third quarter: HARTMANN increases sales in all business segments

The HARTMANN GROUP continued its growth despite the difficult conditions in the health markets. Global sales revenues increased by 5.0 percent to EUR 1,263.8 million compared to the previous year.

Article - 17/12/2012

The ablation of nerves along the renal artery – a novel treatment option in the field of cardiology

High blood pressure can normally be treated effectively with medicines. However, some patients do not respond to medicinal treatment despite several different drugs being used. Renal denervation (RDN), a novel catheter-based procedure, seems to have become a promising alternative to controlling hypertension with drugs. Professor Dr. Axel Bauer from the Tübingen University Hospital believes that this method can even be used for a much wider range…

Article - 10/10/2018

BABYBE GmbH: Premature babies in contact with mum around the clock

It used to be believed that premature babies needed as much rest as possible. However, studies have since shown that this is not the case at all. According to these studies, the brains of premature babies need to be stimulated 24 hours a day, ideally close to the mother, to ensure healthy development. The Stuttgart-based start-up BABYBE GmbH has developed a special gel mattress that enables babies to perceive their mother’s heartbeat and voice…

Press release - 22/03/2011

Bringing artifical vision clinical trials to US

Retina Implant AG Partners with Wills Eye Institute to Bring Artificial Vision Clinical Trials to the United States. Wills Eye to be the Primary Investigation Site to Offer the Subretinal Approach to Retinitis Pigmentosa Patients.

Press release - 06/07/2012

Medicyte is receiving 4.2 Mio Euros from the European Union Seventh Framework Programm

Medicyte, The Electrospinning Company and the Universities of Manchester and Pisa launch a European wide unique project with the aim to design a biomimetic bioartificial liver (Re-Liver). The company GABO:mi ensures professional project management. Research is receiving 4.2 Mio Euros from the European Union Seventh Framework Programme.

As a 100% affiliate of the Baden-Württemberg government, BIOPRO Baden-Württemberg GmbH provides targeted support to the pharmaceutical industry and the biotechnology and medical technology sectors as well as supporting the development of a bioeconomy.